US Patent Issued to Albert-Ludwigs-Universitaet Freiburg on Oct. 14 for "Cobalamin derivatives and their use for the treatment of diseases caused by lack of vitamin B12 supply" (German Inventor)

ALEXANDRIA, Va., Oct. 21 -- United States Patent no. 12,441,758, issued on Oct. 14, was assigned to Albert-Ludwigs-Universitaet Freiburg (Freiburg, Germany).

"Cobalamin derivatives and their use for the treatment of diseases caused by lack of vitamin B12 supply" was invented by Luciana Hannibal (Voerstetten, Germany).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention concerns cobalamin derivatives of formula (I)wherein X is a ligand having a formula selected from among:-(CH2)1-5-S-(CH2)0-3-CH3, -S-(CH2)1-5-NH2 andfurther wherein R1 is H, methyl or ethyl, R2 isand R3 is -H orand its use in diseases caused by lack of vitamin B12 support."

The patent was filed on June 3, 2022, under Applicatio...